Cost-Effectiveness of brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma. Marchetti M, Visco C. Leuk Lymphoma 2023 May 25:1-9. doi: 10.1080/10428194.2023.2215888.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Marchetti M, Visco C. Cost-Effectiveness of brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma. Leuk Lymphoma 2023 May 25:1-9. doi: 10.1080/10428194.2023.2215888.
PMID: 37229538